ARLG is changing the field of clinical research in antimicrobial resistance. We will talk with the Principal Investigators of the ARLG to discuss their strategy
Objectives:
• Review the history and accomplishments of ARLG • Discuss the missions of ARLG including training new clinical investigators focused on antibiotic resistance • Comment of the future of ARLG and clinical research on antibiotic resistance
Joining me to talk about ARLG are the principal investigators of this ambitious effort:
• Dr. Vance Fowler: Professor of Medicine, Florence McAlister Distinguished Professor of Medicine, Professor in Molecular Genetics and Microbiology, Duke University. • Dr. Henry “Chip” Chambers: Professor of Medicine, Emeritus. University of California, San Francisco
Visit aac.asm.org to read the current issue.